Investors are counting on solid earnings growth to propel stocks even higher in 2025, but estimates are showing signs of cooling.
Related Posts
Trump administration swiftly enacts retribution against political enemies
The payback against people who have criticized Trump has ranged in severity, but it’s come quickly, within his first week back in power.
UnitedHealth tumbles 12% on WSJ report the DOJ is investigating Medicare billing practices
The investigation centers on UnitedHealth’s Medicare billing practices.
Eli Lilly posts mixed quarter even as demand for weight loss, diabetes drugs soars
The results were consistent with the preliminary results Eli Lilly shared in January, which disappointed investors.